EY 18th annual Pulse of the MedTech Industry Report
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for…
Global & Trade
Learn more about our Global Affairs work.
AdvaMed Welcomes India, New Member Countries from Latin America, Middle East, Africa to IMDRF
The International Medical Device Regulators Forum (IMDRF) consists of medical device regulators from around the world that voluntarily convene to harmonize the regulatory requirements for medical products varying from country to…
AdvaMed Welcomes APEC Recommendations for Enterprise Integrity and Public Procurement
Lima, Peru – AdvaMed, the Medtech Association, issued the following press release following conclusion of the 2024 Asia-Pacific Economic Cooperation (APEC) Business Ethics for Small- and Medium-Sized Enterprises (SMEs) Forum in…
AdvaMed Signs New MOU with British Medtech Association
AdvaMed, the Medtech Association, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in…
AdvaMed Statement on FDA-USAID India Regulatory Session
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring…
AdvaMed Statement on the World Trade Organization Ministerial Conference
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
AdvaMed Statement on the Sale and Privatization of the Federal Helium Reserve
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply…
AdvaMed Statement on 14th Ministerial Meeting of the United States-India Trade Policy Forum
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
AdvaMed Commends Administration Investment in Domestic Semiconductor Chip Manufacturing
The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely…
Relief Response
In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members…